Global Psoriasis Drug Market Growth 2020-2025
The report requires updating with new data and is sent in 48 hours after order is placed.
According to this study, over the next five years the Psoriasis Drug market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Psoriasis Drug business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Psoriasis Drug market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Psoriasis Drug, covering the supply chain analysis, impact assessment to the Psoriasis Drug market size growth rate in several scenarios, and the measures to be undertaken by Psoriasis Drug companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Research objectives
According to this study, over the next five years the Psoriasis Drug market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Psoriasis Drug business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Psoriasis Drug market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Psoriasis Drug, covering the supply chain analysis, impact assessment to the Psoriasis Drug market size growth rate in several scenarios, and the measures to be undertaken by Psoriasis Drug companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
- External Use
- Oral
- Injection
- Hospital
- Drugs Store
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AbbVie
- LEO Pharma
- Johnson & Johnson
- Galderma
- Bristol-Myers Squibb
- Bayer
- Merz Pharma
- Novartis
- Valeant
- Pfizer
- GlaxoSmithKline
Research objectives
- To study and analyze the global Psoriasis Drug consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
- To understand the structure of Psoriasis Drug market by identifying its various subsegments.
- Focuses on the key global Psoriasis Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
- To analyze the Psoriasis Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
- To project the consumption of Psoriasis Drug submarkets, with respect to key regions (along with their respective key countries).
- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
- To strategically profile the key players and comprehensively analyze their growth strategies.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Psoriasis Drug Consumption 2015-2025
2.1.2 Psoriasis Drug Consumption CAGR by Region
2.2 Psoriasis Drug Segment by Type
2.2.1 External Use
2.2.2 Oral
2.2.3 Injection
2.3 Psoriasis Drug Consumption by Type
2.3.1 Global Psoriasis Drug Consumption Market Share by Type (2015-2020)
2.3.2 Global Psoriasis Drug Revenue and Market Share by Type (2015-2020)
2.3.3 Global Psoriasis Drug Sale Price by Type (2015-2020)
2.4 Psoriasis Drug Segment by Application
2.4.1 Hospital
2.4.2 Drugs Store
2.5 Psoriasis Drug Consumption by Application
2.5.1 Global Psoriasis Drug Consumption Market Share by Type (2015-2020)
2.5.2 Global Psoriasis Drug Value and Market Share by Type (2015-2020)
2.5.3 Global Psoriasis Drug Sale Price by Type (2015-2020)
3 GLOBAL PSORIASIS DRUG BY COMPANY
3.1 Global Psoriasis Drug Sales Market Share by Company
3.1.1 Global Psoriasis Drug Sales by Company (2018-2020)
3.1.2 Global Psoriasis Drug Sales Market Share by Company (2018-2020)
3.2 Global Psoriasis Drug Revenue Market Share by Company
3.2.1 Global Psoriasis Drug Revenue by Company (2018-2020)
3.2.2 Global Psoriasis Drug Revenue Market Share by Company (2018-2020)
3.3 Global Psoriasis Drug Sale Price by Company
3.4 Global Psoriasis Drug Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Psoriasis Drug Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Psoriasis Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 PSORIASIS DRUG BY REGIONS
4.1 Psoriasis Drug by Regions
4.2 Americas Psoriasis Drug Consumption Growth
4.3 APAC Psoriasis Drug Consumption Growth
4.4 Europe Psoriasis Drug Consumption Growth
4.5 Middle East & Africa Psoriasis Drug Consumption Growth
5 AMERICAS
5.1 Americas Psoriasis Drug Consumption by Countries
5.1.1 Americas Psoriasis Drug Consumption by Countries (2015-2020)
5.1.2 Americas Psoriasis Drug Value by Countries (2015-2020)
5.2 Americas Psoriasis Drug Consumption by Type
5.3 Americas Psoriasis Drug Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Psoriasis Drug Consumption by Regions
6.1.1 APAC Psoriasis Drug Consumption by Regions (2015-2020)
6.1.2 APAC Psoriasis Drug Value by Regions (2015-2020)
6.2 APAC Psoriasis Drug Consumption by Type
6.3 APAC Psoriasis Drug Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 EUROPE
7.1 Europe Psoriasis Drug by Countries
7.1.1 Europe Psoriasis Drug Consumption by Countries (2015-2020)
7.1.2 Europe Psoriasis Drug Value by Countries (2015-2020)
7.2 Europe Psoriasis Drug Consumption by Type
7.3 Europe Psoriasis Drug Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Psoriasis Drug by Countries
8.1.1 Middle East & Africa Psoriasis Drug Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Psoriasis Drug Value by Countries (2015-2020)
8.2 Middle East & Africa Psoriasis Drug Consumption by Type
8.3 Middle East & Africa Psoriasis Drug Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 MARKETING, DISTRIBUTORS AND CUSTOMER
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Psoriasis Drug Distributors
10.3 Psoriasis Drug Customer
11 GLOBAL PSORIASIS DRUG MARKET FORECAST
11.1 Global Psoriasis Drug Consumption Forecast (2021-2025)
11.2 Global Psoriasis Drug Forecast by Regions
11.2.1 Global Psoriasis Drug Forecast by Regions (2021-2025)
11.2.2 Global Psoriasis Drug Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast byRegions
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Psoriasis Drug Forecast by Type
11.8 Global Psoriasis Drug Forecast by Application
12 KEY PLAYERS ANALYSIS
12.1 AbbVie
12.1.1 Company Information
12.1.2 Psoriasis Drug Product Offered
12.1.3 AbbVie Psoriasis Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 AbbVie Latest Developments
12.2 LEO Pharma
12.2.1 Company Information
12.2.2 Psoriasis Drug Product Offered
12.2.3 LEO Pharma Psoriasis Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 LEO Pharma Latest Developments
12.3 Johnson & Johnson
12.3.1 Company Information
12.3.2 Psoriasis Drug Product Offered
12.3.3 Johnson & Johnson Psoriasis Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Johnson & Johnson Latest Developments
12.4 Galderma
12.4.1 Company Information
12.4.2 Psoriasis Drug Product Offered
12.4.3 Galderma Psoriasis Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Galderma Latest Developments
12.5 Bristol-Myers Squibb
12.5.1 Company Information
12.5.2 Psoriasis Drug Product Offered
12.5.3 Bristol-Myers Squibb Psoriasis Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Bristol-Myers Squibb Latest Developments
12.6 Bayer
12.6.1 Company Information
12.6.2 Psoriasis Drug Product Offered
12.6.3 Bayer Psoriasis Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Bayer Latest Developments
12.7 Merz Pharma
12.7.1 Company Information
12.7.2 Psoriasis Drug Product Offered
12.7.3 Merz Pharma Psoriasis Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Merz Pharma Latest Developments
12.8 Novartis
12.8.1 Company Information
12.8.2 Psoriasis Drug Product Offered
12.8.3 Novartis Psoriasis Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Novartis Latest Developments
12.9 Valeant
12.9.1 Company Information
12.9.2 Psoriasis Drug Product Offered
12.9.3 Valeant Psoriasis Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Valeant Latest Developments
12.10 Pfizer
12.10.1 Company Information
12.10.2 Psoriasis Drug Product Offered
12.10.3 Pfizer Psoriasis Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Pfizer Latest Developments
12.11 GlaxoSmithKline
12.11.1 Company Information
12.11.2 Psoriasis Drug Product Offered
12.11.3 GlaxoSmithKline Psoriasis Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 GlaxoSmithKline Latest Developments
13 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Psoriasis Drug Consumption 2015-2025
2.1.2 Psoriasis Drug Consumption CAGR by Region
2.2 Psoriasis Drug Segment by Type
2.2.1 External Use
2.2.2 Oral
2.2.3 Injection
2.3 Psoriasis Drug Consumption by Type
2.3.1 Global Psoriasis Drug Consumption Market Share by Type (2015-2020)
2.3.2 Global Psoriasis Drug Revenue and Market Share by Type (2015-2020)
2.3.3 Global Psoriasis Drug Sale Price by Type (2015-2020)
2.4 Psoriasis Drug Segment by Application
2.4.1 Hospital
2.4.2 Drugs Store
2.5 Psoriasis Drug Consumption by Application
2.5.1 Global Psoriasis Drug Consumption Market Share by Type (2015-2020)
2.5.2 Global Psoriasis Drug Value and Market Share by Type (2015-2020)
2.5.3 Global Psoriasis Drug Sale Price by Type (2015-2020)
3 GLOBAL PSORIASIS DRUG BY COMPANY
3.1 Global Psoriasis Drug Sales Market Share by Company
3.1.1 Global Psoriasis Drug Sales by Company (2018-2020)
3.1.2 Global Psoriasis Drug Sales Market Share by Company (2018-2020)
3.2 Global Psoriasis Drug Revenue Market Share by Company
3.2.1 Global Psoriasis Drug Revenue by Company (2018-2020)
3.2.2 Global Psoriasis Drug Revenue Market Share by Company (2018-2020)
3.3 Global Psoriasis Drug Sale Price by Company
3.4 Global Psoriasis Drug Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Psoriasis Drug Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Psoriasis Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 PSORIASIS DRUG BY REGIONS
4.1 Psoriasis Drug by Regions
4.2 Americas Psoriasis Drug Consumption Growth
4.3 APAC Psoriasis Drug Consumption Growth
4.4 Europe Psoriasis Drug Consumption Growth
4.5 Middle East & Africa Psoriasis Drug Consumption Growth
5 AMERICAS
5.1 Americas Psoriasis Drug Consumption by Countries
5.1.1 Americas Psoriasis Drug Consumption by Countries (2015-2020)
5.1.2 Americas Psoriasis Drug Value by Countries (2015-2020)
5.2 Americas Psoriasis Drug Consumption by Type
5.3 Americas Psoriasis Drug Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Psoriasis Drug Consumption by Regions
6.1.1 APAC Psoriasis Drug Consumption by Regions (2015-2020)
6.1.2 APAC Psoriasis Drug Value by Regions (2015-2020)
6.2 APAC Psoriasis Drug Consumption by Type
6.3 APAC Psoriasis Drug Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 EUROPE
7.1 Europe Psoriasis Drug by Countries
7.1.1 Europe Psoriasis Drug Consumption by Countries (2015-2020)
7.1.2 Europe Psoriasis Drug Value by Countries (2015-2020)
7.2 Europe Psoriasis Drug Consumption by Type
7.3 Europe Psoriasis Drug Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Psoriasis Drug by Countries
8.1.1 Middle East & Africa Psoriasis Drug Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Psoriasis Drug Value by Countries (2015-2020)
8.2 Middle East & Africa Psoriasis Drug Consumption by Type
8.3 Middle East & Africa Psoriasis Drug Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 MARKETING, DISTRIBUTORS AND CUSTOMER
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Psoriasis Drug Distributors
10.3 Psoriasis Drug Customer
11 GLOBAL PSORIASIS DRUG MARKET FORECAST
11.1 Global Psoriasis Drug Consumption Forecast (2021-2025)
11.2 Global Psoriasis Drug Forecast by Regions
11.2.1 Global Psoriasis Drug Forecast by Regions (2021-2025)
11.2.2 Global Psoriasis Drug Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast byRegions
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Psoriasis Drug Forecast by Type
11.8 Global Psoriasis Drug Forecast by Application
12 KEY PLAYERS ANALYSIS
12.1 AbbVie
12.1.1 Company Information
12.1.2 Psoriasis Drug Product Offered
12.1.3 AbbVie Psoriasis Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 AbbVie Latest Developments
12.2 LEO Pharma
12.2.1 Company Information
12.2.2 Psoriasis Drug Product Offered
12.2.3 LEO Pharma Psoriasis Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 LEO Pharma Latest Developments
12.3 Johnson & Johnson
12.3.1 Company Information
12.3.2 Psoriasis Drug Product Offered
12.3.3 Johnson & Johnson Psoriasis Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Johnson & Johnson Latest Developments
12.4 Galderma
12.4.1 Company Information
12.4.2 Psoriasis Drug Product Offered
12.4.3 Galderma Psoriasis Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Galderma Latest Developments
12.5 Bristol-Myers Squibb
12.5.1 Company Information
12.5.2 Psoriasis Drug Product Offered
12.5.3 Bristol-Myers Squibb Psoriasis Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Bristol-Myers Squibb Latest Developments
12.6 Bayer
12.6.1 Company Information
12.6.2 Psoriasis Drug Product Offered
12.6.3 Bayer Psoriasis Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Bayer Latest Developments
12.7 Merz Pharma
12.7.1 Company Information
12.7.2 Psoriasis Drug Product Offered
12.7.3 Merz Pharma Psoriasis Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Merz Pharma Latest Developments
12.8 Novartis
12.8.1 Company Information
12.8.2 Psoriasis Drug Product Offered
12.8.3 Novartis Psoriasis Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Novartis Latest Developments
12.9 Valeant
12.9.1 Company Information
12.9.2 Psoriasis Drug Product Offered
12.9.3 Valeant Psoriasis Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Valeant Latest Developments
12.10 Pfizer
12.10.1 Company Information
12.10.2 Psoriasis Drug Product Offered
12.10.3 Pfizer Psoriasis Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Pfizer Latest Developments
12.11 GlaxoSmithKline
12.11.1 Company Information
12.11.2 Psoriasis Drug Product Offered
12.11.3 GlaxoSmithKline Psoriasis Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 GlaxoSmithKline Latest Developments
13 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Research Methodology
Table 2. Data Source
Table 3. Psoriasis Drug Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of External Use
Table 5. Major Players of Oral
Table 6. Major Players of Injection
Table 7. Global Consumption Sales by Type (2015-2020)
Table 8. Global Psoriasis Drug Consumption Market Share by Type (2015-2020)
Table 9. Global Psoriasis Drug Revenue by Type (2015-2020) ($ million)
Table 10. Global Psoriasis Drug Value Market Share by Type (2015-2020) ($ Millions)
Table 11. Global Psoriasis Drug Sale Price by Type (2015-2020)
Table 12. Global Consumption Sales by Application (2015-2020)
Table 13. Global Psoriasis Drug Consumption Market Share by Application (2015-2020)
Table 14. Global Psoriasis Drug Value by Application (2015-2020)
Table 15. Global Psoriasis Drug Value Market Share by Application (2015-2020)
Table 16. Global Psoriasis Drug Sale Price by Application (2015-2020)
Table 17. Global Psoriasis Drug Sales by Company (2017-2019) (K Units)
Table 18. Global Psoriasis Drug Sales Market Share by Company (2017-2019)
Table 19. Global Psoriasis Drug Revenue by Company (2017-2019) ($ Millions)
Table 20. Global Psoriasis Drug Revenue Market Share by Company (2017-2019)
Table 21. Global Psoriasis Drug Sale Price by Company (2017-2019)
Table 22. Global Psoriasis Drug Manufacturing Base Distribution and Sales Area by Manufacturers
Table 23. Players Psoriasis Drug Products Offered
Table 24. Psoriasis Drug Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 25. Global Psoriasis Drug Consumption by Regions 2015-2020 (K Units)
Table 26. Global Psoriasis Drug Consumption Market Share by Regions 2015-2020
Table 27. Global Psoriasis Drug Value by Regions 2015-2020 ($ Millions)
Table 28. Global Psoriasis Drug Value Market Share by Regions 2015-2020
Table 29. Americas Psoriasis Drug Consumption by Countries (2015-2020) (K Units)
Table 30. Americas Psoriasis Drug Consumption Market Share by Countries (2015-2020)
Table 31. Americas Psoriasis Drug Value by Countries (2015-2020) ($ Millions)
Table 32. Americas Psoriasis Drug Value Market Share by Countries (2015-2020)
Table 33. Americas Psoriasis Drug Consumption by Type (2015-2020) (K Units)
Table 34. Americas Psoriasis Drug Consumption Market Share by Type (2015-2020)
Table 35. Americas Psoriasis Drug Consumption by Application (2015-2020) (K Units)
Table 36. Americas Psoriasis Drug Consumption Market Share by Application (2015-2020)
Table 37. APAC Psoriasis Drug Consumption by Regions (2015-2020) (K Units)
Table 38. APAC Psoriasis Drug Consumption Market Share by Regions (2015-2020)
Table 39. APAC Psoriasis Drug Value by Regions (2015-2020) ($ Millions)
Table 40. APAC Psoriasis Drug Value Market Share by Regions (2015-2020)
Table 41. APAC Psoriasis Drug Consumption by Type (2015-2020) (K Units)
Table 42. APAC Psoriasis Drug Consumption Market Share by Type (2015-2020)
Table 43. APAC Psoriasis Drug Consumption by Application (2015-2020) (K Units)
Table 44. APAC Psoriasis Drug Consumption Market Share by Application (2015-2020)
Table 45. Europe Psoriasis Drug Consumption by Countries (2015-2020) (K Units)
Table 46. Europe Psoriasis Drug Consumption Market Share by Countries (2015-2020)
Table 47. Europe Psoriasis Drug Value by Countries (2015-2020) ($ Millions)
Table 48. Europe Psoriasis Drug Value Market Share by Countries (2015-2020)
Table 49. Europe Psoriasis Drug Consumption by Type (2015-2020) (K Units)
Table 50. Europe Psoriasis Drug Consumption Market Share by Type (2015-2020)
Table 51. Europe Psoriasis Drug Consumption by Application (2015-2020) (K Units)
Table 52. Europe Psoriasis Drug Consumption Market Share by Application (2015-2020)
Table 53. Middle East & Africa Psoriasis Drug Consumption by Countries (2015-2020) (K Units)
Table 54. Middle East & Africa Psoriasis Drug Consumption Market Share by Countries (2015-2020)
Table 55. Middle East & Africa Psoriasis Drug Value by Countries (2015-2020) ($ Millions)
Table 56. Middle East & Africa Psoriasis Drug Value Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Psoriasis Drug Consumption by Type (2015-2020) (K Units)
Table 58. Middle East & Africa Psoriasis Drug Consumption Market Share by Type (2015-2020)
Table 59. Middle East & Africa Psoriasis Drug Consumption by Application (2015-2020) (K Units)
Table 60. Middle East & Africa Psoriasis Drug Consumption Market Share by Application (2015-2020)
Table 61. Psoriasis Drug Distributors List
Table 62. Psoriasis Drug Customer List
Table 63. Global Psoriasis Drug Consumption Forecast by Countries (2021-2025) (K Units)
Table 64. Global Psoriasis Drug Consumption Market Forecast by Regions
Table 65. Global Psoriasis Drug Value Forecast by Countries (2021-2025) ($ Millions)
Table 66. Global Psoriasis Drug Value Market Share Forecast by Regions
Table 67. Global Psoriasis Drug Consumption Forecast by Type (2021-2025) (K Units)
Table 68. Global Psoriasis Drug Consumption Market Share Forecast by Type (2021-2025)
Table 69. Global Psoriasis Drug Value Forecast by Type (2021-2025) ($ Millions)
Table 70. Global Psoriasis Drug Value Market Share Forecast by Type (2021-2025)
Table 71. Global Psoriasis Drug Consumption Forecast by Application (2021-2025) (K Units)
Table 72. Global Psoriasis Drug Consumption Market Share Forecast by Application (2021-2025)
Table 73. Global Psoriasis Drug Value Forecast by Application (2021-2025) ($ Millions)
Table 74. Global Psoriasis Drug Value Market Share Forecast by Application (2021-2025)
Table 75. AbbVie Product Offered
Table 76. AbbVie Psoriasis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 77. AbbVie Main Business
Table 78. AbbVie Latest Developments
Table 79. AbbVie Basic Information, Company Total Revenue (in $ million), Psoriasis Drug Manufacturing Base, Sales Area and Its Competitors
Table 80. LEO Pharma Product Offered
Table 81. LEO Pharma Psoriasis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 82. LEO Pharma Main Business
Table 83. LEO Pharma Latest Developments
Table 84. LEO Pharma Basic Information, Company Total Revenue (in $ million), Psoriasis Drug Manufacturing Base, Sales Area and Its Competitors
Table 85. Johnson & Johnson Product Offered
Table 86. Johnson & Johnson Psoriasis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 87. Johnson & Johnson Main Business
Table 88. Johnson & Johnson Latest Developments
Table 89. Johnson & Johnson Basic Information, Company Total Revenue (in $ million), Psoriasis Drug Manufacturing Base, Sales Area and Its Competitors
Table 90. Galderma Product Offered
Table 91. Galderma Psoriasis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 92. Galderma Main Business
Table 93. Galderma Latest Developments
Table 94. Galderma Basic Information, Company Total Revenue (in $ million), Psoriasis Drug Manufacturing Base, Sales Area and Its Competitors
Table 95. Bristol-Myers Squibb Product Offered
Table 96. Bristol-Myers Squibb Psoriasis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 97. Bristol-Myers Squibb Main Business
Table 98. Bristol-Myers Squibb Latest Developments
Table 99. Bristol-Myers Squibb Basic Information, Company Total Revenue (in $ million), Psoriasis Drug Manufacturing Base, Sales Area and Its Competitors
Table 100. Bayer Product Offered
Table 101. Bayer Psoriasis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 102. Bayer Main Business
Table 103. Bayer Latest Developments
Table 104. Bayer Basic Information, Company Total Revenue (in $ million), Psoriasis Drug Manufacturing Base, Sales Area and Its Competitors
Table 105. Merz Pharma Product Offered
Table 106. Merz Pharma Basic Information, Company Total Revenue (in $ million), Psoriasis Drug Manufacturing Base, Sales Area and Its Competitors
Table 107. Merz Pharma Main Business
Table 108. Merz Pharma Latest Developments
Table 109. Merz Pharma Psoriasis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 110. Novartis Product Offered
Table 111. Novartis Psoriasis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 112. Novartis Main Business
Table 113. Novartis Latest Developments
Table 114. Novartis Basic Information, Company Total Revenue (in $ million), Psoriasis Drug Manufacturing Base, Sales Area and Its Competitors
Table 115. Valeant Product Offered
Table 116. Valeant Psoriasis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 117. Valeant Main Business
Table 118. Valeant Latest Developments
Table 119. Valeant Basic Information, Company Total Revenue (in $ million), Psoriasis Drug Manufacturing Base, Sales Area and Its Competitors
Table 120. Pfizer Product Offered
Table 121. Pfizer Psoriasis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 122. Pfizer Main Business
Table 123. Pfizer Latest Developments
Table 124. Pfizer Basic Information, Company Total Revenue (in $ million), Psoriasis Drug Manufacturing Base, Sales Area and Its Competitors
Table 125. GlaxoSmithKline Product Offered
Table 126. GlaxoSmithKline Psoriasis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 127. GlaxoSmithKline Main Business
Table 128. GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 129. GlaxoSmithKline Latest Developments
Table 1. Research Methodology
Table 2. Data Source
Table 3. Psoriasis Drug Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of External Use
Table 5. Major Players of Oral
Table 6. Major Players of Injection
Table 7. Global Consumption Sales by Type (2015-2020)
Table 8. Global Psoriasis Drug Consumption Market Share by Type (2015-2020)
Table 9. Global Psoriasis Drug Revenue by Type (2015-2020) ($ million)
Table 10. Global Psoriasis Drug Value Market Share by Type (2015-2020) ($ Millions)
Table 11. Global Psoriasis Drug Sale Price by Type (2015-2020)
Table 12. Global Consumption Sales by Application (2015-2020)
Table 13. Global Psoriasis Drug Consumption Market Share by Application (2015-2020)
Table 14. Global Psoriasis Drug Value by Application (2015-2020)
Table 15. Global Psoriasis Drug Value Market Share by Application (2015-2020)
Table 16. Global Psoriasis Drug Sale Price by Application (2015-2020)
Table 17. Global Psoriasis Drug Sales by Company (2017-2019) (K Units)
Table 18. Global Psoriasis Drug Sales Market Share by Company (2017-2019)
Table 19. Global Psoriasis Drug Revenue by Company (2017-2019) ($ Millions)
Table 20. Global Psoriasis Drug Revenue Market Share by Company (2017-2019)
Table 21. Global Psoriasis Drug Sale Price by Company (2017-2019)
Table 22. Global Psoriasis Drug Manufacturing Base Distribution and Sales Area by Manufacturers
Table 23. Players Psoriasis Drug Products Offered
Table 24. Psoriasis Drug Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 25. Global Psoriasis Drug Consumption by Regions 2015-2020 (K Units)
Table 26. Global Psoriasis Drug Consumption Market Share by Regions 2015-2020
Table 27. Global Psoriasis Drug Value by Regions 2015-2020 ($ Millions)
Table 28. Global Psoriasis Drug Value Market Share by Regions 2015-2020
Table 29. Americas Psoriasis Drug Consumption by Countries (2015-2020) (K Units)
Table 30. Americas Psoriasis Drug Consumption Market Share by Countries (2015-2020)
Table 31. Americas Psoriasis Drug Value by Countries (2015-2020) ($ Millions)
Table 32. Americas Psoriasis Drug Value Market Share by Countries (2015-2020)
Table 33. Americas Psoriasis Drug Consumption by Type (2015-2020) (K Units)
Table 34. Americas Psoriasis Drug Consumption Market Share by Type (2015-2020)
Table 35. Americas Psoriasis Drug Consumption by Application (2015-2020) (K Units)
Table 36. Americas Psoriasis Drug Consumption Market Share by Application (2015-2020)
Table 37. APAC Psoriasis Drug Consumption by Regions (2015-2020) (K Units)
Table 38. APAC Psoriasis Drug Consumption Market Share by Regions (2015-2020)
Table 39. APAC Psoriasis Drug Value by Regions (2015-2020) ($ Millions)
Table 40. APAC Psoriasis Drug Value Market Share by Regions (2015-2020)
Table 41. APAC Psoriasis Drug Consumption by Type (2015-2020) (K Units)
Table 42. APAC Psoriasis Drug Consumption Market Share by Type (2015-2020)
Table 43. APAC Psoriasis Drug Consumption by Application (2015-2020) (K Units)
Table 44. APAC Psoriasis Drug Consumption Market Share by Application (2015-2020)
Table 45. Europe Psoriasis Drug Consumption by Countries (2015-2020) (K Units)
Table 46. Europe Psoriasis Drug Consumption Market Share by Countries (2015-2020)
Table 47. Europe Psoriasis Drug Value by Countries (2015-2020) ($ Millions)
Table 48. Europe Psoriasis Drug Value Market Share by Countries (2015-2020)
Table 49. Europe Psoriasis Drug Consumption by Type (2015-2020) (K Units)
Table 50. Europe Psoriasis Drug Consumption Market Share by Type (2015-2020)
Table 51. Europe Psoriasis Drug Consumption by Application (2015-2020) (K Units)
Table 52. Europe Psoriasis Drug Consumption Market Share by Application (2015-2020)
Table 53. Middle East & Africa Psoriasis Drug Consumption by Countries (2015-2020) (K Units)
Table 54. Middle East & Africa Psoriasis Drug Consumption Market Share by Countries (2015-2020)
Table 55. Middle East & Africa Psoriasis Drug Value by Countries (2015-2020) ($ Millions)
Table 56. Middle East & Africa Psoriasis Drug Value Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Psoriasis Drug Consumption by Type (2015-2020) (K Units)
Table 58. Middle East & Africa Psoriasis Drug Consumption Market Share by Type (2015-2020)
Table 59. Middle East & Africa Psoriasis Drug Consumption by Application (2015-2020) (K Units)
Table 60. Middle East & Africa Psoriasis Drug Consumption Market Share by Application (2015-2020)
Table 61. Psoriasis Drug Distributors List
Table 62. Psoriasis Drug Customer List
Table 63. Global Psoriasis Drug Consumption Forecast by Countries (2021-2025) (K Units)
Table 64. Global Psoriasis Drug Consumption Market Forecast by Regions
Table 65. Global Psoriasis Drug Value Forecast by Countries (2021-2025) ($ Millions)
Table 66. Global Psoriasis Drug Value Market Share Forecast by Regions
Table 67. Global Psoriasis Drug Consumption Forecast by Type (2021-2025) (K Units)
Table 68. Global Psoriasis Drug Consumption Market Share Forecast by Type (2021-2025)
Table 69. Global Psoriasis Drug Value Forecast by Type (2021-2025) ($ Millions)
Table 70. Global Psoriasis Drug Value Market Share Forecast by Type (2021-2025)
Table 71. Global Psoriasis Drug Consumption Forecast by Application (2021-2025) (K Units)
Table 72. Global Psoriasis Drug Consumption Market Share Forecast by Application (2021-2025)
Table 73. Global Psoriasis Drug Value Forecast by Application (2021-2025) ($ Millions)
Table 74. Global Psoriasis Drug Value Market Share Forecast by Application (2021-2025)
Table 75. AbbVie Product Offered
Table 76. AbbVie Psoriasis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 77. AbbVie Main Business
Table 78. AbbVie Latest Developments
Table 79. AbbVie Basic Information, Company Total Revenue (in $ million), Psoriasis Drug Manufacturing Base, Sales Area and Its Competitors
Table 80. LEO Pharma Product Offered
Table 81. LEO Pharma Psoriasis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 82. LEO Pharma Main Business
Table 83. LEO Pharma Latest Developments
Table 84. LEO Pharma Basic Information, Company Total Revenue (in $ million), Psoriasis Drug Manufacturing Base, Sales Area and Its Competitors
Table 85. Johnson & Johnson Product Offered
Table 86. Johnson & Johnson Psoriasis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 87. Johnson & Johnson Main Business
Table 88. Johnson & Johnson Latest Developments
Table 89. Johnson & Johnson Basic Information, Company Total Revenue (in $ million), Psoriasis Drug Manufacturing Base, Sales Area and Its Competitors
Table 90. Galderma Product Offered
Table 91. Galderma Psoriasis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 92. Galderma Main Business
Table 93. Galderma Latest Developments
Table 94. Galderma Basic Information, Company Total Revenue (in $ million), Psoriasis Drug Manufacturing Base, Sales Area and Its Competitors
Table 95. Bristol-Myers Squibb Product Offered
Table 96. Bristol-Myers Squibb Psoriasis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 97. Bristol-Myers Squibb Main Business
Table 98. Bristol-Myers Squibb Latest Developments
Table 99. Bristol-Myers Squibb Basic Information, Company Total Revenue (in $ million), Psoriasis Drug Manufacturing Base, Sales Area and Its Competitors
Table 100. Bayer Product Offered
Table 101. Bayer Psoriasis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 102. Bayer Main Business
Table 103. Bayer Latest Developments
Table 104. Bayer Basic Information, Company Total Revenue (in $ million), Psoriasis Drug Manufacturing Base, Sales Area and Its Competitors
Table 105. Merz Pharma Product Offered
Table 106. Merz Pharma Basic Information, Company Total Revenue (in $ million), Psoriasis Drug Manufacturing Base, Sales Area and Its Competitors
Table 107. Merz Pharma Main Business
Table 108. Merz Pharma Latest Developments
Table 109. Merz Pharma Psoriasis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 110. Novartis Product Offered
Table 111. Novartis Psoriasis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 112. Novartis Main Business
Table 113. Novartis Latest Developments
Table 114. Novartis Basic Information, Company Total Revenue (in $ million), Psoriasis Drug Manufacturing Base, Sales Area and Its Competitors
Table 115. Valeant Product Offered
Table 116. Valeant Psoriasis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 117. Valeant Main Business
Table 118. Valeant Latest Developments
Table 119. Valeant Basic Information, Company Total Revenue (in $ million), Psoriasis Drug Manufacturing Base, Sales Area and Its Competitors
Table 120. Pfizer Product Offered
Table 121. Pfizer Psoriasis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 122. Pfizer Main Business
Table 123. Pfizer Latest Developments
Table 124. Pfizer Basic Information, Company Total Revenue (in $ million), Psoriasis Drug Manufacturing Base, Sales Area and Its Competitors
Table 125. GlaxoSmithKline Product Offered
Table 126. GlaxoSmithKline Psoriasis Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 127. GlaxoSmithKline Main Business
Table 128. GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 129. GlaxoSmithKline Latest Developments
LIST OF FIGURES
Figure 1. Picture of Psoriasis Drug
Figure 2. Psoriasis Drug Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Psoriasis Drug Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Psoriasis Drug Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of External Use
Figure 7. Product Picture of Oral
Figure 8. Product Picture of Injection
Figure 9. Global Psoriasis Drug Consumption Market Share by Type (2015-2020)
Figure 10. Global Psoriasis Drug Value Market Share by Type (2015-2020)
Figure 11. Psoriasis Drug Consumed in Hospital
Figure 12. Global Psoriasis Drug Market: Hospital (2015-2020) (K Units)
Figure 13. Global Psoriasis Drug Market: Hospital (2015-2020) ($ Millions)
Figure 14. Psoriasis Drug Consumed in Drugs Store
Figure 15. Global Psoriasis Drug Market: Drugs Store (2015-2020) (K Units)
Figure 16. Global Psoriasis Drug Market: Drugs Store (2015-2020) ($ Millions)
Figure 17. Global Psoriasis Drug Consumption Market Share by Application (2015-2020)
Figure 18. Global Psoriasis Drug Value Market Share by Application (2015-2020)
Figure 19. Global Psoriasis Drug Sales Market Share by Company in 2017
Figure 20. Global Psoriasis Drug Sales Market Share by Company in 2019
Figure 21. Global Psoriasis Drug Revenue Market Share by Company in 2017
Figure 22. Global Psoriasis Drug Revenue Market Share by Company in 2019
Figure 23. Global Psoriasis Drug Sale Price by Company in 2019
Figure 24. Global Psoriasis Drug Consumption Market Share by Regions 2015-2020
Figure 25. Global Psoriasis Drug Value Market Share by Regions 2015-2020
Figure 26. Americas Psoriasis Drug Consumption 2015-2020 (K Units)
Figure 27. Americas Psoriasis Drug Value 2015-2020 ($ Millions)
Figure 28. APAC Psoriasis Drug Consumption 2015-2020 (K Units)
Figure 29. APAC Psoriasis Drug Value 2015-2020 ($ Millions)
Figure 30. Europe Psoriasis Drug Consumption 2015-2020 (K Units)
Figure 31. Europe Psoriasis Drug Value 2015-2020 ($ Millions)
Figure 32. Middle East & Africa Psoriasis Drug Consumption 2015-2020 (K Units)
Figure 33. Middle East & Africa Psoriasis Drug Value 2015-2020 ($ Millions)
Figure 34. Americas Psoriasis Drug Consumption Market Share by Countries in 2019
Figure 35. Americas Psoriasis Drug Value Market Share by Countries in 2019
Figure 36. Americas Psoriasis Drug Consumption Market Share by Type in 2019
Figure 37. Americas Psoriasis Drug Consumption Market Share by Application in 2019
Figure 38. United States Psoriasis Drug Consumption Growth 2015-2020 (K Units)
Figure 39. United States Psoriasis Drug Value Growth 2015-2020 ($ Millions)
Figure 40. Canada Psoriasis Drug Consumption Growth 2015-2020 (K Units)
Figure 41. Canada Psoriasis Drug Value Growth 2015-2020 ($ Millions)
Figure 42. Mexico Psoriasis Drug Consumption Growth 2015-2020 (K Units)
Figure 43. Mexico Psoriasis Drug Value Growth 2015-2020 ($ Millions)
Figure 44. APAC Psoriasis Drug Consumption Market Share by Countries in 2019
Figure 45. APAC Psoriasis Drug Value Market Share by Regions in 2019
Figure 46. APAC Psoriasis Drug Consumption Market Share by Type in 2019
Figure 47. APAC Psoriasis Drug Consumption Market Share by Application in 2019
Figure 48. China Psoriasis Drug Consumption Growth 2015-2020 (K Units)
Figure 49. China Psoriasis Drug Value Growth 2015-2020 ($ Millions)
Figure 50. Japan Psoriasis Drug Consumption Growth 2015-2020 (K Units)
Figure 51. Japan Psoriasis Drug Value Growth 2015-2020 ($ Millions)
Figure 52. Korea Psoriasis Drug Consumption Growth 2015-2020 (K Units)
Figure 53. Korea Psoriasis Drug Value Growth 2015-2020 ($ Millions)
Figure 54. Southeast Asia Psoriasis Drug Consumption Growth 2015-2020 (K Units)
Figure 55. Southeast Asia Psoriasis Drug Value Growth 2015-2020 ($ Millions)
Figure 56. India Psoriasis Drug Consumption Growth 2015-2020 (K Units)
Figure 57. India Psoriasis Drug Value Growth 2015-2020 ($ Millions)
Figure 58. Australia Psoriasis Drug Consumption Growth 2015-2020 (K Units)
Figure 59. Australia Psoriasis Drug Value Growth 2015-2020 ($ Millions)
Figure 60. Europe Psoriasis Drug Consumption Market Share by Countries in 2019
Figure 61. Europe Psoriasis Drug Value Market Share by Countries in 2019
Figure 62. Europe Psoriasis Drug Consumption Market Share by Type in 2019
Figure 63. Europe Psoriasis Drug Consumption Market Share by Application in 2019
Figure 64. Germany Psoriasis Drug Consumption Growth 2015-2020 (K Units)
Figure 65. Germany Psoriasis Drug Value Growth 2015-2020 ($ Millions)
Figure 66. France Psoriasis Drug Consumption Growth 2015-2020 (K Units)
Figure 67. France Psoriasis Drug Value Growth 2015-2020 ($ Millions)
Figure 68. UK Psoriasis Drug Consumption Growth 2015-2020 (K Units)
Figure 69. UK Psoriasis Drug Value Growth 2015-2020 ($ Millions)
Figure 70. Italy Psoriasis Drug Consumption Growth 2015-2020 (K Units)
Figure 71. Italy Psoriasis Drug Value Growth 2015-2020 ($ Millions)
Figure 72. Russia Psoriasis Drug Consumption Growth 2015-2020 (K Units)
Figure 73. Russia Psoriasis Drug Value Growth 2015-2020 ($ Millions)
Figure 74. Middle East & Africa Psoriasis Drug Consumption Market Share by Countries in 2019
Figure 75. Middle East & Africa Psoriasis Drug Value Market Share by Countries in 2019
Figure 76. Middle East & Africa Psoriasis Drug Consumption Market Share by Type in 2019
Figure 77. Middle East & Africa Psoriasis Drug Consumption Market Share by Application in 2019
Figure 78. Egypt Psoriasis Drug Consumption Growth 2015-2020 (K Units)
Figure 79. Egypt Psoriasis Drug Value Growth 2015-2020 ($ Millions)
Figure 80. South Africa Psoriasis Drug Consumption Growth 2015-2020 (K Units)
Figure 81. South Africa Psoriasis Drug Value Growth 2015-2020 ($ Millions)
Figure 82. Israel Psoriasis Drug Consumption Growth 2015-2020 (K Units)
Figure 83. Israel Psoriasis Drug Value Growth 2015-2020 ($ Millions)
Figure 84. Turkey Psoriasis Drug Consumption Growth 2015-2020 (K Units)
Figure 85. Turkey Psoriasis Drug Value Growth 2015-2020 ($ Millions)
Figure 86. GCC Countries Psoriasis Drug Consumption Growth 2015-2020 (K Units)
Figure 87. GCC Countries Psoriasis Drug Value Growth 2015-2020 ($ Millions)
Figure 88. Global Psoriasis Drug Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 89. Global Psoriasis Drug Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 90. Americas Psoriasis Drug Consumption 2021-2025 (K Units)
Figure 91. Americas Psoriasis Drug Value 2021-2025 ($ Millions)
Figure 92. APAC Psoriasis Drug Consumption 2021-2025 (K Units)
Figure 93. APAC Psoriasis Drug Value 2021-2025 ($ Millions)
Figure 94. Europe Psoriasis Drug Consumption 2021-2025 (K Units)
Figure 95. Europe Psoriasis Drug Value 2021-2025 ($ Millions)
Figure 96. Middle East & Africa Psoriasis Drug Consumption 2021-2025 (K Units)
Figure 97. Middle East & Africa Psoriasis Drug Value 2021-2025 ($ Millions)
Figure 98. United States Psoriasis Drug Consumption 2021-2025 (K Units)
Figure 99. United States Psoriasis Drug Value 2021-2025 ($ Millions)
Figure 100. Canada Psoriasis Drug Consumption 2021-2025 (K Units)
Figure 101. Canada Psoriasis Drug Value 2021-2025 ($ Millions)
Figure 102. Mexico Psoriasis Drug Consumption 2021-2025 (K Units)
Figure 103. Mexico Psoriasis Drug Value 2021-2025 ($ Millions)
Figure 104. Brazil Psoriasis Drug Consumption 2021-2025 (K Units)
Figure 105. Brazil Psoriasis Drug Value 2021-2025 ($ Millions)
Figure 106. China Psoriasis Drug Consumption 2021-2025 (K Units)
Figure 107. China Psoriasis Drug Value 2021-2025 ($ Millions)
Figure 108. Japan Psoriasis Drug Consumption 2021-2025 (K Units)
Figure 109. Japan Psoriasis Drug Value 2021-2025 ($ Millions)
Figure 110. Korea Psoriasis Drug Consumption 2021-2025 (K Units)
Figure 111. Korea Psoriasis Drug Value 2021-2025 ($ Millions)
Figure 112. Southeast Asia Psoriasis Drug Consumption 2021-2025 (K Units)
Figure 113. Southeast Asia Psoriasis Drug Value 2021-2025 ($ Millions)
Figure 114. India Psoriasis Drug Consumption 2021-2025 (K Units)
Figure 115. India Psoriasis Drug Value 2021-2025 ($ Millions)
Figure 116. Australia Psoriasis Drug Consumption 2021-2025 (K Units)
Figure 117. Australia Psoriasis Drug Value 2021-2025 ($ Millions)
Figure 118. Germany Psoriasis Drug Consumption 2021-2025 (K Units)
Figure 119. Germany Psoriasis Drug Value 2021-2025 ($ Millions)
Figure 120. France Psoriasis Drug Consumption 2021-2025 (K Units)
Figure 121. France Psoriasis Drug Value 2021-2025 ($ Millions)
Figure 122. UK Psoriasis Drug Consumption 2021-2025 (K Units)
Figure 123. UK Psoriasis Drug Value 2021-2025 ($ Millions)
Figure 124. Italy Psoriasis Drug Consumption 2021-2025 (K Units)
Figure 125. Italy Psoriasis Drug Value 2021-2025 ($ Millions)
Figure 126. Russia Psoriasis Drug Consumption 2021-2025 (K Units)
Figure 127. Russia Psoriasis Drug Value 2021-2025 ($ Millions)
Figure 128. Spain Psoriasis Drug Consumption 2021-2025 (K Units)
Figure 129. Spain Psoriasis Drug Value 2021-2025 ($ Millions)
Figure 130. Egypt Psoriasis Drug Consumption 2021-2025 (K Units)
Figure 131. Egypt Psoriasis Drug Value 2021-2025 ($ Millions)
Figure 132. South Africa Psoriasis Drug Consumption 2021-2025 (K Units)
Figure 133. South Africa Psoriasis Drug Value 2021-2025 ($ Millions)
Figure 134. Israel Psoriasis Drug Consumption 2021-2025 (K Units)
Figure 135. Israel Psoriasis Drug Value 2021-2025 ($ Millions)
Figure 136. Turkey Psoriasis Drug Consumption 2021-2025 (K Units)
Figure 137. Turkey Psoriasis Drug Value 2021-2025 ($ Millions)
Figure 138. GCC Countries Psoriasis Drug Consumption 2021-2025 (K Units)
Figure 139. GCC Countries Psoriasis Drug Value 2021-2025 ($ Millions)
Figure 140. AbbVie Psoriasis Drug Market Share (2018-2020)
Figure 141. LEO Pharma Psoriasis Drug Market Share (2018-2020)
Figure 142. Johnson & Johnson Psoriasis Drug Market Share (2018-2020)
Figure 143. Galderma Psoriasis Drug Market Share (2018-2020)
Figure 144. Bristol-Myers Squibb Psoriasis Drug Market Share (2018-2020)
Figure 145. Bayer Psoriasis Drug Market Share (2018-2020)
Figure 146. Merz Pharma Psoriasis Drug Market Share (2018-2020)
Figure 147. Novartis Psoriasis Drug Market Share (2018-2020)
Figure 148. Valeant Psoriasis Drug Market Share (2018-2020)
Figure 149. Pfizer Psoriasis Drug Market Share (2018-2020)
Figure 150. GlaxoSmithKline Psoriasis Drug Market Share (2018-2020)
Figure 1. Picture of Psoriasis Drug
Figure 2. Psoriasis Drug Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Psoriasis Drug Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Psoriasis Drug Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of External Use
Figure 7. Product Picture of Oral
Figure 8. Product Picture of Injection
Figure 9. Global Psoriasis Drug Consumption Market Share by Type (2015-2020)
Figure 10. Global Psoriasis Drug Value Market Share by Type (2015-2020)
Figure 11. Psoriasis Drug Consumed in Hospital
Figure 12. Global Psoriasis Drug Market: Hospital (2015-2020) (K Units)
Figure 13. Global Psoriasis Drug Market: Hospital (2015-2020) ($ Millions)
Figure 14. Psoriasis Drug Consumed in Drugs Store
Figure 15. Global Psoriasis Drug Market: Drugs Store (2015-2020) (K Units)
Figure 16. Global Psoriasis Drug Market: Drugs Store (2015-2020) ($ Millions)
Figure 17. Global Psoriasis Drug Consumption Market Share by Application (2015-2020)
Figure 18. Global Psoriasis Drug Value Market Share by Application (2015-2020)
Figure 19. Global Psoriasis Drug Sales Market Share by Company in 2017
Figure 20. Global Psoriasis Drug Sales Market Share by Company in 2019
Figure 21. Global Psoriasis Drug Revenue Market Share by Company in 2017
Figure 22. Global Psoriasis Drug Revenue Market Share by Company in 2019
Figure 23. Global Psoriasis Drug Sale Price by Company in 2019
Figure 24. Global Psoriasis Drug Consumption Market Share by Regions 2015-2020
Figure 25. Global Psoriasis Drug Value Market Share by Regions 2015-2020
Figure 26. Americas Psoriasis Drug Consumption 2015-2020 (K Units)
Figure 27. Americas Psoriasis Drug Value 2015-2020 ($ Millions)
Figure 28. APAC Psoriasis Drug Consumption 2015-2020 (K Units)
Figure 29. APAC Psoriasis Drug Value 2015-2020 ($ Millions)
Figure 30. Europe Psoriasis Drug Consumption 2015-2020 (K Units)
Figure 31. Europe Psoriasis Drug Value 2015-2020 ($ Millions)
Figure 32. Middle East & Africa Psoriasis Drug Consumption 2015-2020 (K Units)
Figure 33. Middle East & Africa Psoriasis Drug Value 2015-2020 ($ Millions)
Figure 34. Americas Psoriasis Drug Consumption Market Share by Countries in 2019
Figure 35. Americas Psoriasis Drug Value Market Share by Countries in 2019
Figure 36. Americas Psoriasis Drug Consumption Market Share by Type in 2019
Figure 37. Americas Psoriasis Drug Consumption Market Share by Application in 2019
Figure 38. United States Psoriasis Drug Consumption Growth 2015-2020 (K Units)
Figure 39. United States Psoriasis Drug Value Growth 2015-2020 ($ Millions)
Figure 40. Canada Psoriasis Drug Consumption Growth 2015-2020 (K Units)
Figure 41. Canada Psoriasis Drug Value Growth 2015-2020 ($ Millions)
Figure 42. Mexico Psoriasis Drug Consumption Growth 2015-2020 (K Units)
Figure 43. Mexico Psoriasis Drug Value Growth 2015-2020 ($ Millions)
Figure 44. APAC Psoriasis Drug Consumption Market Share by Countries in 2019
Figure 45. APAC Psoriasis Drug Value Market Share by Regions in 2019
Figure 46. APAC Psoriasis Drug Consumption Market Share by Type in 2019
Figure 47. APAC Psoriasis Drug Consumption Market Share by Application in 2019
Figure 48. China Psoriasis Drug Consumption Growth 2015-2020 (K Units)
Figure 49. China Psoriasis Drug Value Growth 2015-2020 ($ Millions)
Figure 50. Japan Psoriasis Drug Consumption Growth 2015-2020 (K Units)
Figure 51. Japan Psoriasis Drug Value Growth 2015-2020 ($ Millions)
Figure 52. Korea Psoriasis Drug Consumption Growth 2015-2020 (K Units)
Figure 53. Korea Psoriasis Drug Value Growth 2015-2020 ($ Millions)
Figure 54. Southeast Asia Psoriasis Drug Consumption Growth 2015-2020 (K Units)
Figure 55. Southeast Asia Psoriasis Drug Value Growth 2015-2020 ($ Millions)
Figure 56. India Psoriasis Drug Consumption Growth 2015-2020 (K Units)
Figure 57. India Psoriasis Drug Value Growth 2015-2020 ($ Millions)
Figure 58. Australia Psoriasis Drug Consumption Growth 2015-2020 (K Units)
Figure 59. Australia Psoriasis Drug Value Growth 2015-2020 ($ Millions)
Figure 60. Europe Psoriasis Drug Consumption Market Share by Countries in 2019
Figure 61. Europe Psoriasis Drug Value Market Share by Countries in 2019
Figure 62. Europe Psoriasis Drug Consumption Market Share by Type in 2019
Figure 63. Europe Psoriasis Drug Consumption Market Share by Application in 2019
Figure 64. Germany Psoriasis Drug Consumption Growth 2015-2020 (K Units)
Figure 65. Germany Psoriasis Drug Value Growth 2015-2020 ($ Millions)
Figure 66. France Psoriasis Drug Consumption Growth 2015-2020 (K Units)
Figure 67. France Psoriasis Drug Value Growth 2015-2020 ($ Millions)
Figure 68. UK Psoriasis Drug Consumption Growth 2015-2020 (K Units)
Figure 69. UK Psoriasis Drug Value Growth 2015-2020 ($ Millions)
Figure 70. Italy Psoriasis Drug Consumption Growth 2015-2020 (K Units)
Figure 71. Italy Psoriasis Drug Value Growth 2015-2020 ($ Millions)
Figure 72. Russia Psoriasis Drug Consumption Growth 2015-2020 (K Units)
Figure 73. Russia Psoriasis Drug Value Growth 2015-2020 ($ Millions)
Figure 74. Middle East & Africa Psoriasis Drug Consumption Market Share by Countries in 2019
Figure 75. Middle East & Africa Psoriasis Drug Value Market Share by Countries in 2019
Figure 76. Middle East & Africa Psoriasis Drug Consumption Market Share by Type in 2019
Figure 77. Middle East & Africa Psoriasis Drug Consumption Market Share by Application in 2019
Figure 78. Egypt Psoriasis Drug Consumption Growth 2015-2020 (K Units)
Figure 79. Egypt Psoriasis Drug Value Growth 2015-2020 ($ Millions)
Figure 80. South Africa Psoriasis Drug Consumption Growth 2015-2020 (K Units)
Figure 81. South Africa Psoriasis Drug Value Growth 2015-2020 ($ Millions)
Figure 82. Israel Psoriasis Drug Consumption Growth 2015-2020 (K Units)
Figure 83. Israel Psoriasis Drug Value Growth 2015-2020 ($ Millions)
Figure 84. Turkey Psoriasis Drug Consumption Growth 2015-2020 (K Units)
Figure 85. Turkey Psoriasis Drug Value Growth 2015-2020 ($ Millions)
Figure 86. GCC Countries Psoriasis Drug Consumption Growth 2015-2020 (K Units)
Figure 87. GCC Countries Psoriasis Drug Value Growth 2015-2020 ($ Millions)
Figure 88. Global Psoriasis Drug Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 89. Global Psoriasis Drug Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 90. Americas Psoriasis Drug Consumption 2021-2025 (K Units)
Figure 91. Americas Psoriasis Drug Value 2021-2025 ($ Millions)
Figure 92. APAC Psoriasis Drug Consumption 2021-2025 (K Units)
Figure 93. APAC Psoriasis Drug Value 2021-2025 ($ Millions)
Figure 94. Europe Psoriasis Drug Consumption 2021-2025 (K Units)
Figure 95. Europe Psoriasis Drug Value 2021-2025 ($ Millions)
Figure 96. Middle East & Africa Psoriasis Drug Consumption 2021-2025 (K Units)
Figure 97. Middle East & Africa Psoriasis Drug Value 2021-2025 ($ Millions)
Figure 98. United States Psoriasis Drug Consumption 2021-2025 (K Units)
Figure 99. United States Psoriasis Drug Value 2021-2025 ($ Millions)
Figure 100. Canada Psoriasis Drug Consumption 2021-2025 (K Units)
Figure 101. Canada Psoriasis Drug Value 2021-2025 ($ Millions)
Figure 102. Mexico Psoriasis Drug Consumption 2021-2025 (K Units)
Figure 103. Mexico Psoriasis Drug Value 2021-2025 ($ Millions)
Figure 104. Brazil Psoriasis Drug Consumption 2021-2025 (K Units)
Figure 105. Brazil Psoriasis Drug Value 2021-2025 ($ Millions)
Figure 106. China Psoriasis Drug Consumption 2021-2025 (K Units)
Figure 107. China Psoriasis Drug Value 2021-2025 ($ Millions)
Figure 108. Japan Psoriasis Drug Consumption 2021-2025 (K Units)
Figure 109. Japan Psoriasis Drug Value 2021-2025 ($ Millions)
Figure 110. Korea Psoriasis Drug Consumption 2021-2025 (K Units)
Figure 111. Korea Psoriasis Drug Value 2021-2025 ($ Millions)
Figure 112. Southeast Asia Psoriasis Drug Consumption 2021-2025 (K Units)
Figure 113. Southeast Asia Psoriasis Drug Value 2021-2025 ($ Millions)
Figure 114. India Psoriasis Drug Consumption 2021-2025 (K Units)
Figure 115. India Psoriasis Drug Value 2021-2025 ($ Millions)
Figure 116. Australia Psoriasis Drug Consumption 2021-2025 (K Units)
Figure 117. Australia Psoriasis Drug Value 2021-2025 ($ Millions)
Figure 118. Germany Psoriasis Drug Consumption 2021-2025 (K Units)
Figure 119. Germany Psoriasis Drug Value 2021-2025 ($ Millions)
Figure 120. France Psoriasis Drug Consumption 2021-2025 (K Units)
Figure 121. France Psoriasis Drug Value 2021-2025 ($ Millions)
Figure 122. UK Psoriasis Drug Consumption 2021-2025 (K Units)
Figure 123. UK Psoriasis Drug Value 2021-2025 ($ Millions)
Figure 124. Italy Psoriasis Drug Consumption 2021-2025 (K Units)
Figure 125. Italy Psoriasis Drug Value 2021-2025 ($ Millions)
Figure 126. Russia Psoriasis Drug Consumption 2021-2025 (K Units)
Figure 127. Russia Psoriasis Drug Value 2021-2025 ($ Millions)
Figure 128. Spain Psoriasis Drug Consumption 2021-2025 (K Units)
Figure 129. Spain Psoriasis Drug Value 2021-2025 ($ Millions)
Figure 130. Egypt Psoriasis Drug Consumption 2021-2025 (K Units)
Figure 131. Egypt Psoriasis Drug Value 2021-2025 ($ Millions)
Figure 132. South Africa Psoriasis Drug Consumption 2021-2025 (K Units)
Figure 133. South Africa Psoriasis Drug Value 2021-2025 ($ Millions)
Figure 134. Israel Psoriasis Drug Consumption 2021-2025 (K Units)
Figure 135. Israel Psoriasis Drug Value 2021-2025 ($ Millions)
Figure 136. Turkey Psoriasis Drug Consumption 2021-2025 (K Units)
Figure 137. Turkey Psoriasis Drug Value 2021-2025 ($ Millions)
Figure 138. GCC Countries Psoriasis Drug Consumption 2021-2025 (K Units)
Figure 139. GCC Countries Psoriasis Drug Value 2021-2025 ($ Millions)
Figure 140. AbbVie Psoriasis Drug Market Share (2018-2020)
Figure 141. LEO Pharma Psoriasis Drug Market Share (2018-2020)
Figure 142. Johnson & Johnson Psoriasis Drug Market Share (2018-2020)
Figure 143. Galderma Psoriasis Drug Market Share (2018-2020)
Figure 144. Bristol-Myers Squibb Psoriasis Drug Market Share (2018-2020)
Figure 145. Bayer Psoriasis Drug Market Share (2018-2020)
Figure 146. Merz Pharma Psoriasis Drug Market Share (2018-2020)
Figure 147. Novartis Psoriasis Drug Market Share (2018-2020)
Figure 148. Valeant Psoriasis Drug Market Share (2018-2020)
Figure 149. Pfizer Psoriasis Drug Market Share (2018-2020)
Figure 150. GlaxoSmithKline Psoriasis Drug Market Share (2018-2020)
